Viking Therapeutics, Inc. (VKTX)
32.16
-1.70
(-5.02%)
USD |
NASDAQ |
Aug 28, 16:00
32.24
+0.08
(+0.25%)
After-Hours: 20:00
Viking Therapeutics 30-Day Average Daily Volume : 1.925M for Aug. 28, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| August 28, 2026 | 1.925M |
| August 27, 2026 | 1.910M |
| August 26, 2026 | 1.887M |
| August 25, 2026 | 1.890M |
| August 24, 2026 | 1.865M |
| August 21, 2026 | 1.873M |
| August 20, 2026 | 1.895M |
| August 19, 2026 | 1.897M |
| August 18, 2026 | 1.919M |
| August 17, 2026 | 2.024M |
| August 14, 2026 | 2.044M |
| August 13, 2026 | 2.088M |
| August 12, 2026 | 2.068M |
| August 11, 2026 | 2.122M |
| August 10, 2026 | 2.185M |
| August 07, 2026 | 2.257M |
| August 06, 2026 | 2.355M |
| August 05, 2026 | 2.497M |
| August 04, 2026 | 2.639M |
| August 03, 2026 | 2.693M |
| July 31, 2026 | 2.753M |
| July 30, 2026 | 2.754M |
| July 29, 2026 | 2.683M |
| July 28, 2026 | 2.626M |
| July 27, 2026 | 2.587M |
| Date | Value |
|---|---|
| July 24, 2026 | 2.613M |
| July 23, 2026 | 2.643M |
| July 22, 2026 | 2.610M |
| July 21, 2026 | 2.635M |
| July 20, 2026 | 2.667M |
| July 17, 2026 | 2.660M |
| July 16, 2026 | 2.645M |
| July 15, 2026 | 2.686M |
| July 14, 2026 | 2.695M |
| July 13, 2026 | 2.709M |
| July 10, 2026 | 2.690M |
| July 09, 2026 | 2.677M |
| July 08, 2026 | 2.700M |
| July 07, 2026 | 2.629M |
| July 06, 2026 | 2.551M |
| July 02, 2026 | 2.535M |
| July 01, 2026 | 2.512M |
| June 30, 2026 | 2.520M |
| June 29, 2026 | 2.475M |
| June 26, 2026 | 2.427M |
| June 25, 2026 | 2.377M |
| June 24, 2026 | 2.276M |
| June 23, 2026 | 2.155M |
| June 22, 2026 | 1.996M |
| June 18, 2026 | 1.950M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Vertex Pharmaceuticals, Inc. | 1.235M |
| Eli Lilly & Co. | 2.643M |
| Regeneron Pharmaceuticals, Inc. | 773592.4 |
| Skye Bioscience, Inc. | 117363.8 |
| Eledon Pharmaceuticals, Inc. | 938609.5 |